Suchergebnisse - "Benzoates"

Ethyl 4-(1H-tetrazol-1-yl)benzoate derivatives as multi-target inhibitors of cancer migration via BTK, BRAF, and FAK modulation: in silico and in vitro studies.

Autoren: Mekky AH Al-Fahad D Okab AK et al.

Quelle: Bioorganic chemistry [Bioorg Chem] 2025 Dec; Vol. 167, pp. 109178. Date of Electronic Publication: 2025 Nov 03.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2120 (Electronic) Linking ISSN: 00452068 NLM ISO Abbreviation: Bioorg Chem Subsets: MEDLINE

MeSH-Schlagworte: Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/chemical synthesis , Protein Kinase Inhibitors*/pharmacology , Protein Kinase Inhibitors*/chemistry , Protein Kinase Inhibitors*/chemical synthesis , Proto-Oncogene Proteins B-raf*/metabolism , Proto-Oncogene Proteins B-raf*/antagonists & inhibitors , Benzoates*/pharmacology , Benzoates*/chemistry , Benzoates*/chemical synthesis , Focal Adhesion Kinase 1*/metabolism , Focal Adhesion Kinase 1*/antagonists & inhibitors, Humans ; Cell Movement/drug effects ; Structure-Activity Relationship ; Drug Screening Assays, Antitumor ; Molecular Structure ; Molecular Docking Simulation ; Dose-Response Relationship, Drug ; Agammaglobulinaemia Tyrosine Kinase/metabolism ; Agammaglobulinaemia Tyrosine Kinase/antagonists & inhibitors ; Animals ; Cell Proliferation/drug effects ; Density Functional Theory ; Cell Line, Tumor ; Chlorocebus aethiops

Successful kidney transplantation using eltrombopag in a patient with MYH9-related disease.

Autoren: Kato A Shirai Y Kanda S et al.

Quelle: CEN case reports [CEN Case Rep] 2025 Dec; Vol. 14 (6), pp. 833-836. Date of Electronic Publication: 2025 Sep 01.

Publikationsart: Journal Article; Case Reports

Info zur Zeitschrift: Publisher: Springer Japan Country of Publication: Japan NLM ID: 101636244 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2192-4449 (Electronic) Linking ISSN: 21924449 NLM ISO Abbreviation: CEN Case Rep Subsets: MEDLINE

MeSH-Schlagworte: Kidney Transplantation*/methods , Benzoates*/therapeutic use , Benzoates*/administration & dosage , Hydrazines*/therapeutic use , Hydrazines*/administration & dosage , Pyrazoles*/therapeutic use , Pyrazoles*/administration & dosage , Thrombocytopenia*/congenital , Thrombocytopenia*/genetics , Thrombocytopenia*/drug therapy , Hearing Loss, Sensorineural*/genetics, Humans ; Female ; Young Adult ; Myosin Heavy Chains/genetics ; Molecular Motor Proteins/genetics ; Living Donors ; Treatment Outcome ; Receptors, Thrombopoietin/agonists ; Platelet Count

SCR Disease Name: MYH9-Related Disorders

Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial.

Autoren: Sockel K Röllig C Mütherig A et al.

Quelle: American journal of hematology [Am J Hematol] 2025 Dec; Vol. 100 (12), pp. 2436-2441. Date of Electronic Publication: 2025 Oct 02.

Publikationsart: Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study; Letter; Journal Article

Info zur Zeitschrift: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

MeSH-Schlagworte: Hydrazines*/administration & dosage , Hydrazines*/therapeutic use , Hydrazines*/adverse effects , Pyrazoles*/administration & dosage , Pyrazoles*/therapeutic use , Pyrazoles*/adverse effects , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/mortality , Leukemia, Myeloid, Acute*/genetics , Benzoates*/administration & dosage , Benzoates*/therapeutic use , Benzoates*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Aged ; Female ; Male ; Aged, 80 and over ; Disease-Free Survival ; Middle Aged ; Azacitidine/administration & dosage ; Azacitidine/analogs & derivatives ; Azacitidine/therapeutic use ; Decitabine/administration & dosage

Conjunctival histopathological changes associated with netarsudil 0.02.

Autoren: Sun MT Charoenkijkajorn C Lin JH et al.

Quelle: Eye (London, England) [Eye (Lond)] 2025 Dec; Vol. 39 (18), pp. 3278-3283. Date of Electronic Publication: 2025 Oct 09.

Publikationsart: Journal Article; Observational Study; Comparative Study

Info zur Zeitschrift: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5454 (Electronic) Linking ISSN: 0950222X NLM ISO Abbreviation: Eye (Lond) Subsets: MEDLINE

MeSH-Schlagworte: Conjunctiva*/pathology , Conjunctiva*/drug effects , Benzoates*/adverse effects , Benzoates*/administration & dosage , beta-Alanine*/analogs & derivatives , beta-Alanine*/adverse effects , beta-Alanine*/administration & dosage , Glaucoma*/drug therapy , Glaucoma*/surgery, Humans ; Female ; Aged ; Male ; Middle Aged ; Aged, 80 and over ; Trabeculectomy ; Intraocular Pressure/drug effects ; Antihypertensive Agents/therapeutic use ; Ophthalmic Solutions

Eltrombopag olamine induces apoptosis in human breast adenocarcinoma and hepatocellular carcinoma cells through modulation of multiple apoptotic pathways.

Autoren: Kabir SR Asaduzzaman M Shahinuzzaman ADA et al.

Quelle: Scientific reports [Sci Rep] 2025 Nov 27; Vol. 15 (1), pp. 42952. Date of Electronic Publication: 2025 Nov 27.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

MeSH-Schlagworte: Apoptosis*/drug effects , Hydrazines*/pharmacology , Hydrazines*/chemistry , Breast Neoplasms*/metabolism , Breast Neoplasms*/pathology , Breast Neoplasms*/drug therapy , Pyrazoles*/pharmacology , Pyrazoles*/chemistry , Carcinoma, Hepatocellular*/metabolism , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/drug therapy , Liver Neoplasms*/metabolism , Liver Neoplasms*/pathology , Liver Neoplasms*/drug therapy , Benzoates*/pharmacology , Benzoates*/chemistry , Antineoplastic Agents*/pharmacology , Adenocarcinoma*/metabolism , Adenocarcinoma*/pathology , Adenocarcinoma*/drug therapy, Humans ; Female ; MCF-7 Cells ; Cell Line, Tumor ; Signal Transduction/drug effects ; Cell Proliferation/drug effects ; HEK293 Cells

Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial.

Autoren: Shimano KA Grimes AB Kaicker S et al.

Quelle: JAMA [JAMA] 2025 Nov 25; Vol. 334 (20), pp. 1816-1826.

Publikationsart: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comment

Info zur Zeitschrift: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

MeSH-Schlagworte: Benzoates*/administration & dosage , Benzoates*/adverse effects , Hydrazines*/administration & dosage , Hydrazines*/adverse effects , Purpura, Thrombocytopenic, Idiopathic*/blood , Purpura, Thrombocytopenic, Idiopathic*/complications , Purpura, Thrombocytopenic, Idiopathic*/drug therapy , Purpura, Thrombocytopenic, Idiopathic*/psychology , Pyrazoles*/administration & dosage , Pyrazoles*/adverse effects , Receptors, Thrombopoietin*/agonists, Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Administration, Oral ; Glucocorticoids/administration & dosage ; Glucocorticoids/adverse effects ; Hemorrhage/epidemiology ; Hemorrhage/etiology ; Hemorrhage/prevention & control ; Immunoglobulins, Intravenous/administration & dosage ; Immunoglobulins, Intravenous/adverse effects ; Platelet Count ; Prospective Studies ; Quality of Life ; Rho(D) Immune Globulin/administration & dosage ; Rho(D) Immune Globulin/adverse effects ; Treatment Outcome

Synthesis of Cellulose Hexanoate, Benzoate, and Mixed Esters: Exploring Their Potential as Enzyme Immobilization Platforms.

Autoren: Teixeira Polez R Voltarelli Ferracini T Cardoso de Paula SF et al.

Quelle: Macromolecular bioscience [Macromol Biosci] 2025 Nov; Vol. 25 (11), pp. e00221. Date of Electronic Publication: 2025 Aug 06.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101135941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1616-5195 (Electronic) Linking ISSN: 16165187 NLM ISO Abbreviation: Macromol Biosci Subsets: MEDLINE

MeSH-Schlagworte: Cellulose*/chemistry , Cellulose*/chemical synthesis , Enzymes, Immobilized*/chemistry , Lipase*/chemistry , Benzoates*/chemistry , Benzoates*/chemical synthesis , Esters*/chemical synthesis , Esters*/chemistry , Caproates*/chemistry , Caproates*/chemical synthesis, Pseudomonas fluorescens/enzymology ; Biocatalysis ; Nanofibers/chemistry

Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia Secondary to Systemic Lupus and Antiphospholipid Syndrome: French Experience With 80 Patients.

Autoren: Marques C Moulis G Roussotte M et al.

Quelle: American journal of hematology [Am J Hematol] 2025 Nov; Vol. 100 (11), pp. 1972-1982. Date of Electronic Publication: 2025 Oct 06.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

MeSH-Schlagworte: Lupus Erythematosus, Systemic*/complications , Lupus Erythematosus, Systemic*/drug therapy , Receptors, Thrombopoietin*/agonists , Antiphospholipid Syndrome*/complications , Antiphospholipid Syndrome*/drug therapy , Thrombopoietin*/adverse effects , Thrombopoietin*/therapeutic use , Thrombopoietin*/administration & dosage , Hydrazines*/therapeutic use , Hydrazines*/adverse effects , Hydrazines*/administration & dosage , Benzoates*/adverse effects , Benzoates*/therapeutic use , Benzoates*/administration & dosage , Purpura, Thrombocytopenic, Idiopathic*/drug therapy , Purpura, Thrombocytopenic, Idiopathic*/etiology , Recombinant Fusion Proteins*/therapeutic use , Recombinant Fusion Proteins*/adverse effects , Recombinant Fusion Proteins*/administration & dosage , Thrombosis*/etiology , Pyrazoles*/adverse effects , Pyrazoles*/therapeutic use , Pyrazoles*/administration & dosage , Receptors, Fc*/therapeutic use , Receptors, Fc*/administration & dosage, Humans ; Female ; Male ; Adult ; Middle Aged ; Retrospective Studies ; France ; Aged ; Young Adult ; Treatment Outcome

Evaluation of astatine-211-labeled benzoate derivatives for improved in vivo stability.

Autoren: Murata M Kannaka K Tatsuta S et al.

Quelle: Nuclear medicine and biology [Nucl Med Biol] 2025 Nov-Dec; Vol. 150-151, pp. 109561. Date of Electronic Publication: 2025 Sep 29.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: United States NLM ID: 9304420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9614 (Electronic) Linking ISSN: 09698051 NLM ISO Abbreviation: Nucl Med Biol Subsets: MEDLINE

MeSH-Schlagworte: Astatine*/chemistry , Astatine*/pharmacokinetics , Astatine*/metabolism , Benzoates*/chemistry , Benzoates*/pharmacokinetics, Animals ; Isotope Labeling ; Tissue Distribution ; Mice ; Rats ; Drug Stability ; Male

Balancing rigidity and flexibility: Optimised 4-(hexyloxy)benzoate antagonists with enhanced affinity and tuneable duration at muscarinic receptors.

Autoren: Dolejší E Mezeiova E Bláhová J et al.

Quelle: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2025 Nov; Vol. 192, pp. 118653. Date of Electronic Publication: 2025 Oct 22.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE

MeSH-Schlagworte: Muscarinic Antagonists*/pharmacology , Muscarinic Antagonists*/chemistry , Muscarinic Antagonists*/chemical synthesis , Muscarinic Antagonists*/metabolism , Benzoates*/pharmacology , Benzoates*/chemistry , Benzoates*/chemical synthesis , Receptors, Muscarinic*/metabolism , Receptors, Muscarinic*/chemistry, Molecular Docking Simulation ; Molecular Dynamics Simulation ; Structure-Activity Relationship ; Animals ; Humans ; CHO Cells ; Cricetulus ; Protein Binding ; Hydrogen Bonding

Synthesis and anticancer evaluation of tri-n-butyltin complexes featuring azomethine- and diazenyl-functionalized benzoates with peripheral fluorine against MDA-MB-231 breast cancer cells.

Autoren: Basu Baul TS Das A Khatiwara A et al.

Quelle: Journal of inorganic biochemistry [J Inorg Biochem] 2025 Nov; Vol. 272, pp. 113013. Date of Electronic Publication: 2025 Jul 24.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Country of Publication: United States NLM ID: 7905788 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3344 (Electronic) Linking ISSN: 01620134 NLM ISO Abbreviation: J Inorg Biochem Subsets: MEDLINE

MeSH-Schlagworte: Azo Compounds*/chemistry , Azo Compounds*/pharmacology , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemical synthesis , Antineoplastic Agents*/chemistry , Thiosemicarbazones*/chemistry , Thiosemicarbazones*/pharmacology , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Benzoates*/chemistry , Benzoates*/pharmacology , Fluorine*/chemistry , Organotin Compounds*/pharmacology , Organotin Compounds*/chemical synthesis , Organotin Compounds*/chemistry, Humans ; Cell Line, Tumor ; Female ; Crystallography, X-Ray ; Drug Screening Assays, Antitumor

The Retinoid Tamibarotene Aggravates Skin Inflammation in a Model of Bullous Pemphigoid-like Epidermolysis Bullosa Acquisita.

Autoren: Thieme M Schilf P Murthy S et al.

Quelle: Cells [Cells] 2025 Oct 23; Vol. 14 (21). Date of Electronic Publication: 2025 Oct 23.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

MeSH-Schlagworte: Tetrahydronaphthalenes*/adverse effects , Tetrahydronaphthalenes*/pharmacology , Epidermolysis Bullosa Acquisita*/pathology , Epidermolysis Bullosa Acquisita*/immunology , Pemphigoid, Bullous*/pathology , Pemphigoid, Bullous*/immunology , Benzoates*/adverse effects , Benzoates*/pharmacology , Retinoids*/adverse effects , Skin*/pathology , Skin*/drug effects , Inflammation*/pathology, Animals ; Mice ; Disease Models, Animal ; T-Lymphocytes, Regulatory/immunology ; T-Lymphocytes, Regulatory/drug effects ; Humans ; Female

New Tetraphenylethylene Benzoic Acid Derivatives as Antibacterial Agents for Gram-Positive Bacteria with Ultralow Inhibition Concentration.

Autoren: Guo X Peng Y Zhang M et al.

Quelle: Bioconjugate chemistry [Bioconjug Chem] 2025 Oct 15; Vol. 36 (10), pp. 2305-2316. Date of Electronic Publication: 2025 Sep 29.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9010319 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4812 (Electronic) Linking ISSN: 10431802 NLM ISO Abbreviation: Bioconjug Chem Subsets: MEDLINE

MeSH-Schlagworte: Anti-Bacterial Agents*/pharmacology , Anti-Bacterial Agents*/chemistry , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/chemical synthesis , Staphylococcus aureus*/drug effects , Stilbenes*/chemistry , Stilbenes*/pharmacology , Benzoic Acid*/pharmacology , Benzoic Acid*/chemistry , Gram-Positive Bacteria*/drug effects , Benzoates*/chemistry , Benzoates*/pharmacology, Microbial Sensitivity Tests ; Animals ; Mice ; Biofilms/drug effects ; Staphylococcal Infections/drug therapy ; Staphylococcal Infections/microbiology ; Structure-Activity Relationship

Multicenter, real-world observational study of AVA therapy following ELT/HET switching in Chinese children with persistent/chronic primary ITP.

Autoren: Liu J Wang Z Wang N et al.

Quelle: Annals of hematology [Ann Hematol] 2025 Oct; Vol. 104 (10), pp. 5027-5035. Date of Electronic Publication: 2025 Sep 11.

Publikationsart: Journal Article; Multicenter Study; Observational Study

Info zur Zeitschrift: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

MeSH-Schlagworte: Benzoates*/administration & dosage , Benzoates*/adverse effects , Benzoates*/therapeutic use , Drug Substitution* , Hydrazines*/administration & dosage , Hydrazines*/adverse effects , Hydrazines*/therapeutic use , Purpura, Thrombocytopenic, Idiopathic*/drug therapy , Purpura, Thrombocytopenic, Idiopathic*/blood , Purpura, Thrombocytopenic, Idiopathic*/epidemiology , Pyrazoles*/administration & dosage , Pyrazoles*/adverse effects , Pyrazoles*/therapeutic use , Receptors, Thrombopoietin*/agonists , Thiazoles*/administration & dosage , Thiazoles*/adverse effects , Thiazoles*/therapeutic use, Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; China/epidemiology ; Chronic Disease ; Cohort Studies ; Treatment Outcome ; East Asian People ; Thiophenes

Eltrombopag-Induced Falsely Elevated Bilirubin Concentrations in Enzymatic and Vanadate Oxidation Assays: Involvement of High Serum Eltrombopag Concentrations.

Autoren: Oda S Doki K Obara N et al.

Quelle: Therapeutic drug monitoring [Ther Drug Monit] 2025 Oct 01; Vol. 47 (5), pp. 635-640. Date of Electronic Publication: 2025 Feb 05.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3694 (Electronic) Linking ISSN: 01634356 NLM ISO Abbreviation: Ther Drug Monit Subsets: MEDLINE

MeSH-Schlagworte: Hydrazines*/blood , Hydrazines*/adverse effects , Benzoates*/blood , Benzoates*/adverse effects , Bilirubin*/blood , Pyrazoles*/blood , Pyrazoles*/adverse effects , Vanadates*/chemistry , Vanadates*/metabolism, Humans ; Male ; Female ; Oxidation-Reduction/drug effects ; Anemia, Aplastic/drug therapy ; Anemia, Aplastic/blood ; Middle Aged ; Adult ; Enzyme Assays/methods ; Aged ; False Positive Reactions

Eltrombopag for Bone Marrow Failure in Fanconi Anemia: Results From the Phase II Clinical Trial FANCREV.

Autoren: Iriondo J Zubicaray J Río P et al.

Quelle: European journal of haematology [Eur J Haematol] 2025 Oct; Vol. 115 (4), pp. 403-412. Date of Electronic Publication: 2025 Jul 16.

Publikationsart: Journal Article; Clinical Trial, Phase II

Info zur Zeitschrift: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

MeSH-Schlagworte: Hydrazines*/therapeutic use , Hydrazines*/adverse effects , Hydrazines*/administration & dosage , Benzoates*/therapeutic use , Benzoates*/adverse effects , Benzoates*/administration & dosage , Pyrazoles*/therapeutic use , Pyrazoles*/adverse effects , Pyrazoles*/administration & dosage , Fanconi Anemia*/drug therapy , Fanconi Anemia*/complications , Fanconi Anemia*/diagnosis , Fanconi Anemia*/genetics , Bone Marrow*/pathology , Bone Marrow*/drug effects , Bone Marrow*/metabolism , Bone Marrow Diseases*/drug therapy , Bone Marrow Diseases*/etiology, Humans ; Child ; Male ; Female ; Child, Preschool ; Treatment Outcome

Efficacy and safety of romiplostim and eltrombopag in management of thrombocytopenia in Wiskott-Aldrich syndrome patients.

Autoren: Ogneva A Rodina Y Pershin D et al.

Quelle: British journal of haematology [Br J Haematol] 2025 Oct; Vol. 207 (4), pp. 1558-1564. Date of Electronic Publication: 2025 May 21.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

MeSH-Schlagworte: Benzoates*/adverse effects , Benzoates*/therapeutic use , Benzoates*/administration & dosage , Hydrazines*/adverse effects , Hydrazines*/therapeutic use , Hydrazines*/administration & dosage , Thrombopoietin*/adverse effects , Thrombopoietin*/therapeutic use , Thrombopoietin*/administration & dosage , Recombinant Fusion Proteins*/adverse effects , Recombinant Fusion Proteins*/therapeutic use , Recombinant Fusion Proteins*/administration & dosage , Receptors, Fc*/therapeutic use , Receptors, Fc*/administration & dosage , Pyrazoles*/adverse effects , Pyrazoles*/therapeutic use , Pyrazoles*/administration & dosage , Thrombocytopenia*/drug therapy , Thrombocytopenia*/etiology , Thrombocytopenia*/blood , Wiskott-Aldrich Syndrome*/drug therapy , Wiskott-Aldrich Syndrome*/complications , Wiskott-Aldrich Syndrome*/blood, Humans ; Adolescent ; Child, Preschool ; Child ; Male ; Female ; Infant ; Receptors, Thrombopoietin/agonists ; Platelet Count ; Treatment Outcome ; Infant, Newborn ; Prospective Studies

Comparison of Dorzolamide and Netarsudil on Intraocular Pressure and Ocular Perfusion in Early Glaucoma: A Randomized Controlled Trial.

Autoren: Angmo D Jain V Warjri GB et al.

Quelle: Journal of glaucoma [J Glaucoma] 2025 Dec 01; Vol. 34 (12), pp. 1046-1055. Date of Electronic Publication: 2025 Jul 29.

Publikationsart: Journal Article; Randomized Controlled Trial; Comparative Study

Info zur Zeitschrift: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 9300903 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-481X (Electronic) Linking ISSN: 10570829 NLM ISO Abbreviation: J Glaucoma Subsets: MEDLINE

MeSH-Schlagworte: Intraocular Pressure*/drug effects , Intraocular Pressure*/physiology , Sulfonamides*/therapeutic use , Thiophenes*/therapeutic use , beta-Alanine*/analogs & derivatives , beta-Alanine*/therapeutic use , Optic Disk*/blood supply , Benzoates*/therapeutic use , Carbonic Anhydrase Inhibitors*/therapeutic use , Glaucoma, Open-Angle*/drug therapy , Glaucoma, Open-Angle*/physiopathology , Glaucoma, Open-Angle*/diagnosis , Antihypertensive Agents*/therapeutic use, Humans ; Male ; Female ; Tomography, Optical Coherence ; Prospective Studies ; Middle Aged ; Retinal Ganglion Cells/pathology ; Aged ; Fluorescein Angiography ; Nerve Fibers/pathology ; Tonometry, Ocular ; Retinal Vessels ; Ophthalmic Solutions ; Regional Blood Flow

Core-shell Au@4-MBA@Ag enhanced SERS immunochromatography for rapid and on-site detection of deoxynivalenol in animal feeds.

Autoren: Song X He Z Tan S et al.

Quelle: Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2025 Dec; Vol. 417 (30), pp. 6851-6863. Date of Electronic Publication: 2025 Oct 21.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134327 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-2650 (Electronic) Linking ISSN: 16182642 NLM ISO Abbreviation: Anal Bioanal Chem Subsets: MEDLINE

MeSH-Schlagworte: Trichothecenes*/analysis , Animal Feed*/analysis , Gold*/chemistry , Spectrum Analysis, Raman*/methods , Metal Nanoparticles*/chemistry , Food Contamination*/analysis , Silver*/chemistry , Chromatography, Affinity*/methods , Sulfhydryl Compounds*/chemistry , Benzoates*/chemistry, Limit of Detection ; Immunoassay/methods ; Animals ; Biosensing Techniques/methods ; Mycotoxins/analysis

Effect of eltrombopag on biochemical assay parameters.

Autoren: Nakano K Seimiya M Kojima K et al.

Quelle: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2025 Nov 15; Vol. 265, pp. 117015. Date of Electronic Publication: 2025 Jun 06.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-264X (Electronic) Linking ISSN: 07317085 NLM ISO Abbreviation: J Pharm Biomed Anal Subsets: MEDLINE

MeSH-Schlagworte: Hydrazines* , Benzoates*/adverse effects , Pyrazoles* , Bilirubin*/blood, Humans ; Male ; Female ; Middle Aged ; Thrombocytopenia/drug therapy ; Thrombocytopenia/blood ; Aged ; Triglycerides/blood ; Adult ; Hyperlipidemias/blood